TABLE 1.
Clinical isolate | Isolation site | No. of isolates | MIC (mg/liter) |
||||
---|---|---|---|---|---|---|---|
FAM | FOM | TGC | VAN | DAP | |||
S. aureus | Prosthetic joint infection | 13 | 1 (0.5-64)a | 4 (0.25-64) | 0.125 (0.01-0.25) | 0.5 (0.5-1) | 0.125 (0.06-0.5) |
CoNS | Prosthetic joint infection | 6 | 1 (0.25-2) | 16 (4-64) | 0.06 (0.01-0.25) | 2 (1-2) | 0.125 (0.06-0.25) |
S. aureus | Preoperative skin | 1 | 0.25 | 64 | 0.06 | 0.5 | 0.125 |
CoNS | Preoperative skin | 14 | 0.25 (0.06-16) | 32 (0.5-64) | 0.03 (0.01-0.5) | 0.75 (0.5-2) | 0.250 (0.01-0.25) |
Control strains | |||||||
SEK8 | Skin of healthy control | 0.25 | 16 | 0.125 | 1 | 0.25 | |
ATCC 29213 | Reference strain | 0.5 | 4 | 0.06 | 0.5 | 0.125 | |
DSM3269 | Reference strain | 0.5 | 1 | 0.5 | 2 | 0.25 |
Values in parentheses are the MIC50 ranges for the clinical isolates.